Arcutis Biotherapeutics, Inc. (ARQT)
25.10
+0.98
(+4.06%)
USD |
NASDAQ |
Apr 14, 16:00
25.50
+0.40
(+1.59%)
After-Hours: 20:00
Arcutis Biotherapeutics Cash from Investing (TTM) : -30.25M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| ADMA Biologics, Inc. | -21.89M |
| Axsome Therapeutics, Inc. | -0.48M |
| Arcus Biosciences, Inc. | 66.00M |
| Stoke Therapeutics, Inc. | -186.81M |